Clinical Trial: Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Psychological Morbidity and Facial Volume in HIV Lipodystrophy:
Brief Summary:
The hypotheses of this study were that:
- HIV lipodystrophy is associated with psychological morbidity relating to body image, anxiety and depression.
- Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or Bio-alcamid, is associated with an improvement in psychological morbidity and anatomical volume of treated areas.
- The DI3D system is a valid and reproducible method of recording and measuring facial 3-D volume.
Detailed Summary: as above
Sponsor: NHS Lothian
Current Primary Outcome: measurement of 3-D facial volume [ Time Frame: 2 years ]
Original Primary Outcome: measrement of 3-D facial volume [ Time Frame: 2 years ]
Current Secondary Outcome: psychological outcome [ Time Frame: 2 years ]
Original Secondary Outcome: Same as current
Information By: NHS Lothian
Dates:
Date Received: May 23, 2011
Date Started: August 2006
Date Completion:
Last Updated: June 9, 2011
Last Verified: March 2006